Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate®

Wheezing phenotypes and prediction of asthma in young children

Theresa W Guilbert, MD
Robert F Lemanske, Jr, MD
Section Editor
Gregory Redding, MD
Deputy Editor
Elizabeth TePas, MD, MS


Parents of infants and young children with recurrent wheezing often ask, "Does my child have asthma?" This is a question that clinicians involved in patient care and also those researching asthma would like to be able to answer. Preschool wheezing, a symptom that can herald the subsequent development of childhood asthma, is a common problem worldwide [1]. However, the condition improves and ultimately disappears by school years in many children. Proper identification of infants and young children at increased risk to develop persistent asthma may help predict long-term outcomes and improve prevention and treatment, but the ability to identify these children remains limited.

Several classifications of wheezing phenotypes and other tools have been developed in an effort to categorize children with recurrent wheezing and determine which will ultimately develop asthma. These wheezing phenotypes and predictive tools are reviewed in this topic. The definition and diagnosis of asthma in children; asthma risk factors, genetics, and natural history; bronchiolitis and virus-induced wheezing; and other causes of wheezing in children are discussed separately. (See "Asthma in children younger than 12 years: Initial evaluation and diagnosis" and "Asthma in children younger than 12 years: Epidemiology and pathophysiology" and "Natural history of asthma" and "Genetics of asthma" and "Risk factors for asthma" and "Approach to wheezing in infants and children" and "Wheezing illnesses other than asthma in children" and "Virus-induced wheezing and asthma: An overview" and "Treatment of recurrent virus-induced wheezing in young children" and "Bronchiolitis in infants and children: Clinical features and diagnosis".)


Almost 50 percent of children are reported to have wheezing in the first year of life, although only 20 percent will experience continued wheezing symptoms in later childhood [2]. Wheezing phenotypes have been defined to identify the characteristics and risk factors associated with children that experience wheezing [3]. Some of these phenotypes describe children who continue to wheeze until later childhood, while others identify those who continue to wheeze through adolescence and adulthood. However, the relationship between risk factors and the subsequent development of asthma in later childhood and adult life is not clear.

Many of these early childhood wheezing phenotypes were determined retrospectively in longitudinal studies. However, it can be difficult to clinically distinguish among these phenotypes during the preschool years because of the variation in expression of both symptoms and risk factors over time. In addition, the application of these phenotypes to diverse populations is not established, and it is not clear which are the most effective therapies for a particular wheezing phenotype or whether early intervention can alter the course and outcome over time.

Epidemiologic phenotypes — Several epidemiologic phenotypes, based upon wheezing history, have been developed. There is some variability in age cutoffs differentiating among transient, persistent, and late-onset wheezing and inconsistencies in which risk factors are associated with each phenotype. There are also concerns about the prospective validity of these phenotypes.


Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Feb 2017. | This topic last updated: Wed Feb 22 00:00:00 GMT+00:00 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Garcia-Marcos L, Mallol J, Solé D, et al. International study of wheezing in infants: risk factors in affluent and non-affluent countries during the first year of life. Pediatr Allergy Immunol 2010; 21:878.
  2. Martinez FD, Wright AL, Taussig LM, et al. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995; 332:133.
  3. Spycher BD, Silverman M, Kuehni CE. Phenotypes of childhood asthma: are they real? Clin Exp Allergy 2010; 40:1130.
  4. Rusconi F, Galassi C, Corbo GM, et al. Risk factors for early, persistent, and late-onset wheezing in young children. SIDRIA Collaborative Group. Am J Respir Crit Care Med 1999; 160:1617.
  5. Stein RT, Holberg CJ, Morgan WJ, et al. Peak flow variability, methacholine responsiveness and atopy as markers for detecting different wheezing phenotypes in childhood. Thorax 1997; 52:946.
  6. Martinez FD. What have we learned from the Tucson Children's Respiratory Study? Paediatr Respir Rev 2002; 3:193.
  7. Stein RT, Martinez FD. Asthma phenotypes in childhood: lessons from an epidemiological approach. Paediatr Respir Rev 2004; 5:155.
  8. Sherriff A, Peters TJ, Henderson J, et al. Risk factor associations with wheezing patterns in children followed longitudinally from birth to 3(1/2) years. Int J Epidemiol 2001; 30:1473.
  9. Henderson J, Granell R, Heron J, et al. Associations of wheezing phenotypes in the first 6 years of life with atopy, lung function and airway responsiveness in mid-childhood. Thorax 2008; 63:974.
  10. Savenije OE, Granell R, Caudri D, et al. Comparison of childhood wheezing phenotypes in 2 birth cohorts: ALSPAC and PIAMA. J Allergy Clin Immunol 2011; 127:1505.
  11. Just J, Gouvis-Echraghi R, Couderc R, et al. Novel severe wheezy young children phenotypes: boys atopic multiple-trigger and girls nonatopic uncontrolled wheeze. J Allergy Clin Immunol 2012; 130:103.
  12. Brand PL, Baraldi E, Bisgaard H, et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J 2008; 32:1096.
  13. Sonnappa S, Bastardo CM, Wade A, et al. Symptom-pattern phenotype and pulmonary function in preschool wheezers. J Allergy Clin Immunol 2010; 126:519.
  14. Schultz A, Devadason SG, Savenije OE, et al. The transient value of classifying preschool wheeze into episodic viral wheeze and multiple trigger wheeze. Acta Paediatr 2010; 99:56.
  15. Depner M, Fuchs O, Genuneit J, et al. Clinical and epidemiologic phenotypes of childhood asthma. Am J Respir Crit Care Med 2014; 189:129.
  16. Stern DA, Morgan WJ, Halonen M, et al. Wheezing and bronchial hyper-responsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: a longitudinal birth-cohort study. Lancet 2008; 372:1058.
  17. Lowe LA, Simpson A, Woodcock A, et al. Wheeze phenotypes and lung function in preschool children. Am J Respir Crit Care Med 2005; 171:231.
  18. Kurukulaaratchy RJ, Fenn MH, Waterhouse LM, et al. Characterization of wheezing phenotypes in the first 10 years of life. Clin Exp Allergy 2003; 33:573.
  19. Martinez F, Godfrey S. Wheezing disorders in the preschool child: Pathogenesis and management, 1st ed, Martin Dunitz, New York 2003.
  20. Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999; 354:541.
  21. Pereira MU, Sly PD, Pitrez PM, et al. Nonatopic asthma is associated with helminth infections and bronchiolitis in poor children. Eur Respir J 2007; 29:1154.
  22. Just J, Saint-Pierre P, Gouvis-Echraghi R, et al. Wheeze phenotypes in young children have different courses during the preschool period. Ann Allergy Asthma Immunol 2013; 111:256.
  23. Guilbert TW, Morgan WJ, Zeiger RS, et al. Atopic characteristics of children with recurrent wheezing at high risk for the development of childhood asthma. J Allergy Clin Immunol 2004; 114:1282.
  24. Smith JA, Drake R, Simpson A, et al. Dimensions of respiratory symptoms in preschool children: population-based birth cohort study. Am J Respir Crit Care Med 2008; 177:1358.
  25. Oostveen E, Dom S, Desager K, et al. Lung function and bronchodilator response in 4-year-old children with different wheezing phenotypes. Eur Respir J 2010; 35:865.
  26. Lodge CJ, Lowe AJ, Allen KJ, et al. Childhood wheeze phenotypes show less than expected growth in FEV1 across adolescence. Am J Respir Crit Care Med 2014; 189:1351.
  27. Håland G, Carlsen KC, Sandvik L, et al. Reduced lung function at birth and the risk of asthma at 10 years of age. N Engl J Med 2006; 355:1682.
  28. Turner SW, Palmer LJ, Rye PJ, et al. The relationship between infant airway function, childhood airway responsiveness, and asthma. Am J Respir Crit Care Med 2004; 169:921.
  29. Morgan WJ, Stern DA, Sherrill DL, et al. Outcome of asthma and wheezing in the first 6 years of life: follow-up through adolescence. Am J Respir Crit Care Med 2005; 172:1253.
  30. Illi S, von Mutius E, Lau S, et al. Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study. Lancet 2006; 368:763.
  31. Bisgaard H, Hermansen MN, Bønnelykke K, et al. Association of bacteria and viruses with wheezy episodes in young children: prospective birth cohort study. BMJ 2010; 341:c4978.
  32. Kloepfer KM, Lee WM, Pappas TE, et al. Detection of pathogenic bacteria during rhinovirus infection is associated with increased respiratory symptoms and asthma exacerbations. J Allergy Clin Immunol 2014; 133:1301.
  33. Jackson DJ, Gangnon RE, Evans MD, et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med 2008; 178:667.
  34. Lemanske RF Jr, Jackson DJ, Gangnon RE, et al. Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol 2005; 116:571.
  35. Holt PG, Upham JW, Sly PD. Contemporaneous maturation of immunologic and respiratory functions during early childhood: implications for development of asthma prevention strategies. J Allergy Clin Immunol 2005; 116:16.
  36. Holt PG, Sly PD. Prevention of allergic respiratory disease in infants: current aspects and future perspectives. Curr Opin Allergy Clin Immunol 2007; 7:547.
  37. Franz A, Adams O, Willems R, et al. Correlation of viral load of respiratory pathogens and co-infections with disease severity in children hospitalized for lower respiratory tract infection. J Clin Virol 2010; 48:239.
  38. Lynch SV, Wood RA, Boushey H, et al. Effects of early-life exposure to allergens and bacteria on recurrent wheeze and atopy in urban children. J Allergy Clin Immunol 2014; 134:593.
  39. Loss GJ, Depner M, Hose AJ, et al. The Early Development of Wheeze. Environmental Determinants and Genetic Susceptibility at 17q21. Am J Respir Crit Care Med 2016; 193:889.
  40. Lowe L, Murray CS, Martin L, et al. Reported versus confirmed wheeze and lung function in early life. Arch Dis Child 2004; 89:540.
  41. Skytt N, Bønnelykke K, Bisgaard H. "To wheeze or not to wheeze": That is not the question. J Allergy Clin Immunol 2012; 130:403.
  42. Castro-Rodríguez JA, Holberg CJ, Wright AL, Martinez FD. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med 2000; 162:1403.
  43. Castro-Rodriguez JA. The Asthma Predictive Index: a very useful tool for predicting asthma in young children. J Allergy Clin Immunol 2010; 126:212.
  44. Castro-Rodriguez JA. The Asthma Predictive Index: early diagnosis of asthma. Curr Opin Allergy Clin Immunol 2011; 11:157.
  45. Leonardi NA, Spycher BD, Strippoli MP, et al. Validation of the Asthma Predictive Index and comparison with simpler clinical prediction rules. J Allergy Clin Immunol 2011; 127:1466.
  46. Fouzas S, Brand PL. Predicting persistence of asthma in preschool wheezers: crystal balls or muddy waters? Paediatr Respir Rev 2013; 14:46.
  47. Savenije OE, Kerkhof M, Koppelman GH, Postma DS. Predicting who will have asthma at school age among preschool children. J Allergy Clin Immunol 2012; 130:325.
  48. Brand PL. The Asthma Predictive Index: not a useful tool in clinical practice. J Allergy Clin Immunol 2011; 127:293.
  49. Rodriguez-Martinez CE, Sossa-Briceño MP, Castro-Rodriguez JA. Discriminative properties of two predictive indices for asthma diagnosis in a sample of preschoolers with recurrent wheezing. Pediatr Pulmonol 2011; 46:1175.
  50. National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol 2007; 120:S94.
  51. Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006; 354:1985.
  52. Chang TS, Lemanske RF Jr, Guilbert TW, et al. Evaluation of the modified asthma predictive index in high-risk preschool children. J Allergy Clin Immunol Pract 2013; 1:152.
  53. Amin P, Levin L, Epstein T, et al. Optimum predictors of childhood asthma: persistent wheeze or the Asthma Predictive Index? J Allergy Clin Immunol Pract 2014; 2:709.
  54. Kurukulaaratchy RJ, Matthews S, Holgate ST, Arshad SH. Predicting persistent disease among children who wheeze during early life. Eur Respir J 2003; 22:767.
  55. Pescatore AM, Dogaru CM, Duembgen L, et al. A simple asthma prediction tool for preschool children with wheeze or cough. J Allergy Clin Immunol 2014; 133:111.
  56. Vial Dupuy A, Amat F, Pereira B, et al. A simple tool to identify infants at high risk of mild to severe childhood asthma: the persistent asthma predictive score. J Asthma 2011; 48:1015.
  57. Devulapalli CS, Carlsen KC, Håland G, et al. Severity of obstructive airways disease by age 2 years predicts asthma at 10 years of age. Thorax 2008; 63:8.
  58. Caudri D, Wijga A, A Schipper CM, et al. Predicting the long-term prognosis of children with symptoms suggestive of asthma at preschool age. J Allergy Clin Immunol 2009; 124:903.
  59. Hafkamp-de Groen E, Lingsma HF, Caudri D, et al. Predicting asthma in preschool children with asthma-like symptoms: validating and updating the PIAMA risk score. J Allergy Clin Immunol 2013; 132:1303.
  60. Caudri D, Wijga AH, Hoekstra MO, et al. Prediction of asthma in symptomatic preschool children using exhaled nitric oxide, Rint and specific IgE. Thorax 2010; 65:801.
  61. van der Mark LB, van Wonderen KE, Mohrs J, et al. Predicting asthma in preschool children at high risk presenting in primary care: development of a clinical asthma prediction score. Prim Care Respir J 2014; 23:52.
  62. Guerra S, Lohman IC, Halonen M, et al. Reduced interferon gamma production and soluble CD14 levels in early life predict recurrent wheezing by 1 year of age. Am J Respir Crit Care Med 2004; 169:70.
  63. Stern DA, Guerra S, Halonen M, et al. Low IFN-gamma production in the first year of life as a predictor of wheeze during childhood. J Allergy Clin Immunol 2007; 120:835.
  64. Krawiec ME, Westcott JY, Chu HW, et al. Persistent wheezing in very young children is associated with lower respiratory inflammation. Am J Respir Crit Care Med 2001; 163:1338.
  65. Saglani S, Malmström K, Pelkonen AS, et al. Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. Am J Respir Crit Care Med 2005; 171:722.
  66. Saglani S, Payne DN, Zhu J, et al. Early detection of airway wall remodeling and eosinophilic inflammation in preschool wheezers. Am J Respir Crit Care Med 2007; 176:858.
  67. Barbato A, Turato G, Baraldo S, et al. Epithelial damage and angiogenesis in the airways of children with asthma. Am J Respir Crit Care Med 2006; 174:975.
  68. Rothers J, Halonen M, Stern DA, et al. Adaptive cytokine production in early life differentially predicts total IgE levels and asthma through age 5 years. J Allergy Clin Immunol 2011; 128:397.
  69. Hoshino M, Matsuoka S, Handa H, et al. Correlation between airflow limitation and airway dimensions assessed by multidetector CT in asthma. Respir Med 2010; 104:794.
  70. Aysola RS, Hoffman EA, Gierada D, et al. Airway remodeling measured by multidetector CT is increased in severe asthma and correlates with pathology. Chest 2008; 134:1183.
  71. Hall IP, Wheatley A, Christie G, et al. Association of CCR5 delta32 with reduced risk of asthma. Lancet 1999; 354:1264.
  72. O'Donnell AR, Toelle BG, Marks GB, et al. Age-specific relationship between CD14 and atopy in a cohort assessed from age 8 to 25 years. Am J Respir Crit Care Med 2004; 169:615.
  73. Khoo SK, Hayden CM, Roberts M, et al. Associations of the IL12B promoter polymorphism in longitudinal data from asthmatic patients 7 to 42 years of age. J Allergy Clin Immunol 2004; 113:475.
  74. Kabesch M, Schedel M, Carr D, et al. IL-4/IL-13 pathway genetics strongly influence serum IgE levels and childhood asthma. J Allergy Clin Immunol 2006; 117:269.
  75. Palmer CN, Ismail T, Lee SP, et al. Filaggrin null mutations are associated with increased asthma severity in children and young adults. J Allergy Clin Immunol 2007; 120:64.
  76. Basu K, Palmer CN, Lipworth BJ, et al. Filaggrin null mutations are associated with increased asthma exacerbations in children and young adults. Allergy 2008; 63:1211.
  77. Fitzpatrick AM, Teague WG, Meyers DA, et al. Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program. J Allergy Clin Immunol 2011; 127:382.